HAPILA’s BTZ-043 anti TB agent commences human trials

Thursday 9th January 2020

By HAPILA GmbH Learn More >

Wednesday 8th January 2020

By Bachem AG Learn More >

Tuesday 7th January 2020

By TAmiRNA GmbH Learn More >

Monday 6th January 2020

By Applikon Biotechnology… Learn More >

Friday 20th December 2019

By Applikon Biotechnology… Learn More >

$Academic study confirms TAmiRNA osteomiR™ as promising biomarker for predicting fracture risk$

Friday 13th December 2019

By TAmiRNA GmbH Learn More >

Wednesday 11th December 2019

By Bonfiglioli Engineering… Learn More >

Friday 6th December 2019

By Particle Analytical… Learn More >

Friday 6th December 2019

By MEGGLE Excipients… Learn More >

Tuesday 3rd December 2019

By Dec Group Learn More >

Tuesday 3rd December 2019

By Applikon Biotechnology… Learn More >

Monday 2nd December 2019

By PHOENIX group Learn More >

Subscribe to Supplier